Not Medicare Enrolled

Dr. Korey Ullrich, M.D.

Rheumatology · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1050 NW 15TH ST, Boca Raton, FL 33486
5613682125
In practice since 2008 (18 years)
NPI: 1639342124 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ullrich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ullrich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ullrich

Dr. Korey Ullrich is a rheumatology in Boca Raton, FL, with 18 years in practice. Based on federal Medicare data, Dr. Ullrich performed 55,043 Medicare services across 5,536 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ullrich received a total of $578,987 from 44 pharmaceutical and/or device companies across 2152 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ullrich is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 36% volume in FL$ $578,987 industry payments

Medicare Practice Summary

Medicare Utilization ↗
55,043
Medicare services
Top 36% in FL for rheumatology
5,536
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,058 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)21,421$18$25
Romosozumab injection (Evenity) for osteoporosis13,230$8$15
Certolizumab injection (Cimzia)9,600$4$10
Abatacept infusion (Orencia)2,400$34$60
Office visit, established patient (30-39 min)954$97$271
Blood draw (venipuncture)796$8$10
Blood creatinine level594$5$12
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle556$59$138
Calcium level, total540$5$12
Vitamin D level test452$29$73
Office visit, established patient (20-29 min)439$68$191
Liver function blood test panel350$8$20
Complete blood count (CBC) with differential335$8$19
Red blood cell sedimentation rate, to detect inflammation, non-automated321$4$9
C-reactive protein test (inflammation marker)321$5$13
Urea nitrogen level to assess kidney function, quantitative236$4$10
Blood sodium level189$5$10
Blood glucose (sugar) level187$4$10
Blood potassium level187$5$10
Injection, methylprednisolone acetate, 40 mg155$6$12
Measurement of complement (immune system proteins), antigen,142$12$59
Injection, zoledronic acid, 1 mg135$7$45
Phosphate level test123$5$11
Bone density scan (DEXA)118$39$79
Measurement of antibody for assessment of autoimmune disorder, any method118$18$89
Parathyroid hormone level test115$40$102
New patient office visit (45-59 min)87$126$354
Phosphatase (enzyme) measurement, alkaline, isoenzymes81$14$30
Administration of chemotherapy into vein, 1 hour or less67$98$205
Thyroid stimulating hormone (TSH) test61$16$42
Measurement of dna antibody, native or double stranded60$13$34
Injection into tendon or ligament54$38$120
Office visit, established patient, complex (40-54 min)53$136$379
Aspiration and/or injection of fluid large joint using ultrasound guidance50$76$212
Telephone medical discussion with physician, 11-20 minutes44$72$115
X-ray of hand, 2 views43$24$65
Telephone medical discussion with physician, 5-10 minutes34$41$75
X-ray of knee, 1-2 views33$28$71
Rheumatoid factor analysis33$6$14
Uric acid level test29$4$11
Analysis of substance using immunoassay technique, multiple step method28$11$28
Screening test for autoimmune disorder28$12$30
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$50$105
Joint injection, major joint25$54$146
X-ray of wrist, 2 views24$27$70
Ultrasonic guidance for needle placement21$46$185
X-ray of lower and sacral spine, 2-3 views18$33$79
Creatine kinase (cardiac enzyme) level, total18$6$16
New patient office visit, complex (60-74 min)18$178$468
Shoulder X-ray, 2+ views17$27$71
X-ray of foot, 2 views16$20$59
Destruction of nerve branches of knee using imaging guidance13$121$300
Cortisol (hormone) measurement, total13$16$40
New patient office visit (30-44 min)12$93$237
X-ray of upper spine, 4-5 views11$39$109
X-ray of middle spine, 2 views11$27$68
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
82.3% medium
13.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$578,987
Total received (2018-2024)
Avg $82,712/year across 7 years
Top 3% in FL for rheumatology
44
Companies
2,152
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$529,153 (91.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$33,955 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,879 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$95,945
2023
$121,992
2022
$90,853
2021
$16,759
2020
$37,662
2019
$103,468
2018
$112,308

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$216,032
Amgen Inc.
$158,048
Horizon Pharma plc
$84,988
Horizon Therapeutics plc
$36,291
AbbVie, Inc.
$16,522
GENZYME CORPORATION
$13,006
Novartis Pharmaceuticals Corporation
$11,045
Janssen Biotech, Inc.
$9,082
AbbVie Inc.
$8,150
Janssen Scientific Affairs, LLC
$6,001
GlaxoSmithKline, LLC.
$5,404
UCB, Inc.
$3,219
Regeneron Healthcare Solutions, Inc.
$3,042
Sandoz Inc.
$1,596
PFIZER INC.
$1,058
Radius Health, Inc.
$903
E.R. Squibb & Sons, L.L.C.
$847
ABBVIE INC.
$603
Mallinckrodt Hospital Products Inc.
$512
Genentech USA, Inc.
$275
AstraZeneca Pharmaceuticals LP
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$231
SANOFI-AVENTIS U.S. LLC
$220
Celgene Corporation
$211
Mallinckrodt Enterprises LLC
$173
Mallinckrodt LLC
$160
Actelion Pharmaceuticals US, Inc.
$154
Sobi, Inc
$150
MEDEXUS PHARMA, INC.
$127
Takeda Pharmaceuticals U.S.A., Inc.
$113
SOBI, INC
$103
Aurinia Pharma U.S., Inc.
$91
Alvogen Inc
$69
Alexion Pharmaceuticals, Inc.
$55
Merck Sharp & Dohme Corporation
$42
Fresenius Kabi USA, LLC
$38
Avanos Medical
$36
SCILEX PHARMACEUTICALS INC.
$19
Organon LLC
$19
Hikma Pharmaceuticals USA
$18
Vertical Pharmaceuticals, LLC
$18
Bioventus LLC
$18
Ultragenyx Pharmaceutical Inc.
$17
Organon Llc
$11
Top 3 companies account for 79.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · Bimzelx · COLOGUARD DNA CAPTURE REAGENTS · COOLIEF* COOLED RADIOFREQUENCY · COSENTYX · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN 3 · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LORZONE · LUMIZYME · LUPKYNIS · LYRICA · Mitigare · NA · NO PRODUCT DISCUSSED · NUCALA · OFEV · OLUMIANT · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for rheumatology in FL.

Equivalent to $1,052 per 100 Medicare services performed
Looking for a rheumatology in Boca Raton?
Compare rheumatologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
67
Per 100K population
4.4
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ullrich is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ullrich experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ullrich performed 21,421 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ullrich receive payments from pharmaceutical companies?
Yes. Dr. Ullrich received a total of $578,987 from 44 companies across 2,152 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ullrich's costs compare to other rheumatologys in Boca Raton?
Dr. Ullrich's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ullrich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →